Two groups derived neural and mesodermal cells from human fibroblasts by going through a partially reprogrammed intermediate.
Subject terms:
- Stem Cells
- Cell Biology
- Genetics
The ability to easily convert accessible human cells into disease-relevant cell types through cellular reprogramming has opened new doors for basic research and regenerative medicine1. Takahashi and Yamanaka ushered in contemporary reprogramming when they demonstrated that a combination of four transcription factors (Oct3/4, Sox2, Klf4 and c-Myc) could drive skin-derived fibroblasts to a pluripotent state that could be further differentiated into the desired cell type2 (Fig. 1a). But robust differentiation into specific lineages remains a stumbling block. Low efficiencies and week- to month-long protocols often give rise to mixed cultures requiring a second purification step. Purity matters, as remnant pluripotent cells can give rise to tumors after transplantation. Moreover, the yielded cells are typically immature (as in cardiomyocyte, hematopoietic or neuronal differentiation).